New data from the Centers for Disease Control and Prevention demonstrates the effectiveness of vaccines against the coronavirus, as incidents of COVID-19 fell the most among those targeted for vaccination early on in the campaign. In a new study, the CDC found that incidents of the disease fell for every age group beginning in January,… Read More »
Advertisement Continue reading the main story Supported by Continue reading the main story A Vaccine Side Effect Leaves Women Wondering: Why Isn’t the Pill Safer? Scientists were alarmed by blood clots possibly linked to the J&J vaccine. Some women wondered if there shouldn’t be more concern about oral contraceptives. Kelly Tyrrell, an ultramarathon runner in… Read More »
Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »
The Coronavirus Outbreak liveLatest Updates Maps and Cases Vaccine Rollout Second Dose Outdoor Mask Guidance Josie Nixon of Denver, Colo. had to select “other” for her gender when registering for a Covid vaccine. There was no option for “transgender woman.”Credit…Caleb Alvarado for The New York Times SectionsSkip to contentSkip to site index In Covid Vaccine… Read More »
Sergeant Jennifer Callender (L) of the Illinois Air National Guard administers a Pfizer Covid-19 vaccine to Virginia Persha at a vaccination center established at the Triton College in River Grove, Illinois, on February 3, 2021. Kamil Krzaczynski | AFP | Getty Images Pfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines… Read More »